Hi,
Correct me if I'm wrong but as I understand it, the data is saying this:
1. At albuminuria level of > 500mg/mol = reduction of 18%. (Out of the 40, 26 people had 500mg/mol or higher)
2. Out of the 26, 64% had a reduction of 25% or more in albuminuria level.
3. Across the whole population tested (40), no significant difference between placebo and dmx-200. The reason being both placebo and dmx reduced albuminuria levels. dmx200 showed a reduction of 14% and placebo a reduction of 12% hence no significant difference. Hence, more data is needed to know about legacy effect and why the placebo did good things (-12%).
Data needs some understanding but a careful reading should ease the worries. Management is simply trying to tell us that the result is statistically significant at albuminuria level of 500mg/mmol. Just have to get more data to explain why the placebo also worked. Make no mistake, it's a placebo. If a placebo could do magic like that, we don't need to figure out this disease.
Check the presentation slides and the announcement for confirmation.
Stay cool holders..
- Potential downside will be independent from the results e.g. if any hindrances on REMAP results etc.
- IMO there is plenty of upside.
- Sure it could slide some more if markets keep dropping, but im a happy camper holding.
Can't wait for more explanation. Not many biotech companies at this value going into Phase 3 studies.
- Forums
- ASX - By Stock
- DXB
- Ann: Positive Top-Line Results in DKD Phase 2 Clinical Study
Ann: Positive Top-Line Results in DKD Phase 2 Clinical Study, page-341
-
-
- There are more pages in this discussion • 287 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DXB (ASX) to my watchlist
(20min delay)
|
|||||
Last
40.0¢ |
Change
-0.005(1.23%) |
Mkt cap ! $222.9M |
Open | High | Low | Value | Volume |
42.5¢ | 43.0¢ | 39.8¢ | $436.4K | 1.067M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 24999 | 40.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
41.0¢ | 11224 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 24999 | 0.400 |
7 | 117116 | 0.395 |
6 | 70531 | 0.390 |
5 | 87463 | 0.385 |
16 | 309556 | 0.380 |
Price($) | Vol. | No. |
---|---|---|
0.410 | 11224 | 1 |
0.415 | 23569 | 2 |
0.420 | 62900 | 2 |
0.425 | 43979 | 2 |
0.430 | 125221 | 8 |
Last trade - 16.10pm 31/10/2024 (20 minute delay) ? |
Featured News
DXB (ASX) Chart |